Basic self-disorders may play a role in the development of depression in schizophrenia: a seven-year follow-up study

Depression is the most common co-morbid psychiatric disorder in patients with schizophrenia and has a negative effect on functional outcomes and quality of life. There are several possible pathways leading to depressive symptoms in schizophrenia. Self-disorders are disturbances in the deepest, pre-r...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in psychiatry Vol. 15; p. 1521366
Main Authors Haug, Elisabeth, Øie, Merete Glenne, Svendsen, Ingrid Hartveit, Møller, Paul, Nelson, Barnaby, Melle, Ingrid
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 08.01.2025
Subjects
Online AccessGet full text
ISSN1664-0640
1664-0640
DOI10.3389/fpsyt.2024.1521366

Cover

More Information
Summary:Depression is the most common co-morbid psychiatric disorder in patients with schizophrenia and has a negative effect on functional outcomes and quality of life. There are several possible pathways leading to depressive symptoms in schizophrenia. Self-disorders are disturbances in the deepest, pre-reflective level of the self and are suggested to be core features of schizophrenia. The relationship between self-disorders, and depressive symptoms has only been studied to a limited extent, and there are no longitudinal studies. This study aimed to explore the relationship between self-disorders at baseline and the development of depression over the follow-up period. Self-disorders were examined with the Examination of Anomalous Self-Experience (EASE) instrument in 31 patients with schizophrenia during their first treatment. Seven years later we measured the total number of depressive episodes since the start of treatment. We found a clear association between self-disorders at baseline and the total number of depressive episodes over the follow-up period. Self-disorders may play a role in the development of depression in schizophrenia. This may have implications for therapeutic approaches targeting a condition that is characterized by considerable suffering and an elevated risk of suicide.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
NFR/287714
David H. V. Vogel, University Hospital of Cologne, Germany
Edited by: Anne Giersch, Institut National de la Santé et de la Recherche Médicale (INSERM), France
Reviewed by: Michele Poletti, IRCCS Local Health Authority of Reggio Emilia, Italy
ISSN:1664-0640
1664-0640
DOI:10.3389/fpsyt.2024.1521366